论文部分内容阅读
目的:观察胸腺肽联合玉屏风口服液治疗小儿反复呼吸道感染的临床疗效。方法:将86例患者按照随机数字表法分为2组各43例。对照组接受常规治疗和胸腺肽;治疗组在对照组基础上给予玉屏风口服液。观察2组临床疗效,监测免疫指标变化。结果:总有效率对照组65.1%。治疗组88.4%,治疗组的总有效率高于对照组,差异有显著性意义(P<0.05)。治疗后,2组的IgG都升高(P<0.05),治疗组中IgG变化幅度优于对照组,差异有显著性意义(P<0.05)。结论:胸腺肽联合玉屏风口服液治疗小儿反复呼吸道感染疗效显著,不良反应少。
Objective: To observe the clinical efficacy of thymosin combined with Yupingfeng oral liquid in treatment of recurrent respiratory tract infections in children. Methods: According to the random number table, 86 patients were divided into two groups of 43 cases. The control group received routine treatment and thymosin; the treatment group was given Yupingfeng oral liquid on the basis of the control group. The clinical effects of the two groups were observed and the changes of immune indexes were monitored. Results: The total effective rate in control group was 65.1%. The treatment group, 88.4%, the total effective rate of the treatment group than the control group, the difference was significant (P <0.05). After treatment, the IgG in both groups increased (P <0.05), and the variation of IgG in the treatment group was better than that in the control group (P <0.05). Conclusion: The therapeutic effect of thymosin combined with Yupingfeng oral liquid on recurrent respiratory tract infections in children is remarkable with few adverse reactions.